Patent Yard Sign in
Expired Canadian patentCanada

Pharmaceutical composition containing fenofibrate and preparation method

CA 2377909 C · Owner: Chenevier, Philippe · Inventors: Chenevier, Philippe; Suplie, Pascal; Criere, Bruno

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention concerns a pharmaceutical composition containing micronized fenofibrate a surfactant and a binding cellulose derivative as solubilizing adjuvant, preferably hydroxypropylmethylcellulose. The cellulose derivative represents less than 20 wt. % of the composition. The association of micronized fenofibrate with a binding cellulose derivative as solubilizing adjuvant and a surfactant enables to enhance the bioavailability of the active principle. The invention also concerns a method for preparing said composition without using any organic solvent.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 7, 2000 and granted June 28, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 7, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 7, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 7, 2000
GrantedJune 28, 2011
Term endedJuly 7, 2020
Patent numberCA 2377909 C
Classification (IPC)A61K31/21 +1 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedJuly 7, 2000Patent grantedJune 28, 2011Term endedJuly 7, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.